J Aging Health:老年人听力损失和助听器使用相关的特性和健康结果分析

2019-05-27 AlexYang MedSci原创

最近,有研究人员招募了老年人来探索与听力损失(HL)和助听器使用相关的生理和社会心理情况和其他健康结果。研究人员利用调查数据将20244名参与者分成了5个组:非HL组、无助听器轻度HL组、助听器轻度HL组、无助听器重度HL组和助听器重度HL组。研究发现,无助听器重度HL组个体更可能报道差到一般水平的自我评估健康情况,并且不太可能离开家里或者每周锻炼4-7天,而在那些助听器轻度或者重度HL组中没有上

最近,有研究人员招募了老年人来探索与听力损失(HL)和助听器使用相关的生理和社会心理情况和其他健康结果。

研究人员利用调查数据将20244名参与者分成了5个组:非HL组、无助听器轻度HL组、助听器轻度HL组、无助听器重度HL组和助听器重度HL组。研究发现,无助听器重度HL组个体更可能报道差到一般水平的自我评估健康情况,并且不太可能离开家里或者每周锻炼4-7天,而在那些助听器轻度或者重度HL组中没有上述相关性。另外,那些具有助听器的患者不太可能报道抑郁、低社会支持或者移动限制。

最后,研究人员指出,在一些例子中,助听器使用能够减少HL与消极的社会心理、身体特征以及健康结果的相关性。利用纵向性研究设计的更多的研究是需要的,从而更好的理解这些发现的真正应用。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1861323, encodeId=162c186132323, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Jan 17 00:52:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306374, encodeId=718913063e4e9, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307942, encodeId=67c6130e942bf, content=<a href='/topic/show?id=c2e8333e6d8' target=_blank style='color:#2F92EE;'>#助听器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33376, encryptionId=c2e8333e6d8, topicName=助听器)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621802, encodeId=a343162180279, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=)]
    2020-01-17 shizhenshan
  2. [GetPortalCommentsPageByObjectIdResponse(id=1861323, encodeId=162c186132323, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Jan 17 00:52:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306374, encodeId=718913063e4e9, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307942, encodeId=67c6130e942bf, content=<a href='/topic/show?id=c2e8333e6d8' target=_blank style='color:#2F92EE;'>#助听器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33376, encryptionId=c2e8333e6d8, topicName=助听器)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621802, encodeId=a343162180279, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=)]
    2019-05-29 ysjykql
  3. [GetPortalCommentsPageByObjectIdResponse(id=1861323, encodeId=162c186132323, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Jan 17 00:52:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306374, encodeId=718913063e4e9, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307942, encodeId=67c6130e942bf, content=<a href='/topic/show?id=c2e8333e6d8' target=_blank style='color:#2F92EE;'>#助听器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33376, encryptionId=c2e8333e6d8, topicName=助听器)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621802, encodeId=a343162180279, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1861323, encodeId=162c186132323, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Jan 17 00:52:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306374, encodeId=718913063e4e9, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307942, encodeId=67c6130e942bf, content=<a href='/topic/show?id=c2e8333e6d8' target=_blank style='color:#2F92EE;'>#助听器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33376, encryptionId=c2e8333e6d8, topicName=助听器)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621802, encodeId=a343162180279, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Wed May 29 03:52:00 CST 2019, time=2019-05-29, status=1, ipAttribution=)]

相关资讯

英国NHS招聘200名药剂师,解决老年人过度用药问题

在NHS长期计划中,通过药剂师和药房技术人员来解决老年人过度用药的问题,已经作为改善老年人健康和护理措施的一部分。

Semin Arthritis Rheu:老年类风湿性关节炎患者使用生物制剂的疗效和安全性

报告的结局存在明显异质性,并且除了抗TNF药物以外,其他生物制剂的研究很少。

J Am Geriatr Soc:听力困难与患者低水平积极度相关

患者的积极度涉及了知识、技巧和信心,从而帮助成年人积极的参与他们的医疗保健。听力损失患者由于听力沟通不良参加的能力有限。最近,有研究人员调查了是否听力困难与低水平的患者积极度相关。研究包括了一个国家代表性的美国样本,年龄在65岁及以上(n=13940)。自我报道的听力困难包括没有问题、有点问题和问题很大。总的积极度通过相应的调查问卷来评估:低积极度(低于平均-0.5SDs),高积极度(高于平均+0